Gilead Sciences Inc. Q3 adjusted earnings Beat Estimates

(RTTNews) - Gilead Sciences Inc. (GILD) revealed earnings for third quarter that decreased from the same period last year.

The company's bottom line totaled $2.10 billion, or $1.60 per share. This compares with $2.72 billion, or $2.06 per share, in last year's third quarter.

Excluding items, Gilead Sciences Inc. reported adjusted earnings of $2.40 billion or $1.84 per share for the period.

Analysts had expected the company to earn $1.63 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter fell 14.1% to $5.60 billion from $6.52 billion last year.

Gilead Sciences Inc. earnings at a glance:

-Earnings (Q3): $2.40 Bln. vs. $2.99 Bln. last year. -EPS (Q3): $1.84 vs. $2.27 last year. -Analysts Estimate: $1.63 -Revenue (Q3): $5.60 Bln vs. $6.52 Bln last year.

-Guidance: Full year EPS guidance: $1.50 - $1.60 Full year revenue guidance: $20800 - $21300 Mln